These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21895678)

  • 1. The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands.
    Prinsze FJ; Zaaijer HL
    Vox Sang; 2012 Apr; 102(3):198-203. PubMed ID: 21895678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood safety strategies for human T-cell lymphotropic virus in Europe.
    Laperche S; Worms B; Pillonel J; ;
    Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infection with T-lymphotropic virus in Dutch blood donors, 1993-1996].
    Zaaijer HL; Lelie PN; van der Poel CL
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1571-2. PubMed ID: 9543753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil.
    Namen-Lopes MS; Martins ML; Drummond PC; Lobato RR; ; Carneiro-Proietti AB
    Transfus Med; 2009 Aug; 19(4):180-8. PubMed ID: 19706135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK; Bhatti FA; Salamat N
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010.
    Hakre S; Manak MM; Murray CK; Davis KW; Bose M; Harding AJ; Maas PR; Jagodzinski LL; Kim JH; Michael NL; Rentas FJ; Peel SA; Scott PT; Tovanabutra S
    Transfusion; 2013 Oct; 53(10):2176-82. PubMed ID: 23362944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Grandinetti T; Poiesz BJ; Ehrlich GD
    Arch Intern Med; 1991 Oct; 151(10):2043-8. PubMed ID: 1929693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
    Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
    Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel.
    Stienlauf S; Yahalom V; Shinar E; Sidi Y; Segal G; Schwartz E
    Int J Infect Dis; 2013 Nov; 17(11):e1022-4. PubMed ID: 23642569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening blood products for HTLV-I: what is the best approach?
    Vesilind GW; Koepke JA; DesHarnais GR
    Transfus Sci; 1990; 11(1):103-12. PubMed ID: 10149525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of additional blood screening tests in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
    Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia.
    Styles CE; Seed CR; Hoad VC; Gaudieri S; Keller AJ
    Vox Sang; 2017 Nov; 112(8):723-732. PubMed ID: 28960337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
    Murphy EL
    Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy.
    Williams P; O'Flaherty N; Field S; Waters A
    Transfusion; 2022 Sep; 62(9):1799-1807. PubMed ID: 35829653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
    Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
    Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.